Bringing Discoveries to Commercialization
Indiana Center for Biomedical Innovation interns wrap up summer session

Indiana Center for Biomedical Innovation interns wrap up summer session

Friday, August 30, 2019

Interns and mentors are finishing their summer research with the Indiana Center for Biomedical Innovation (ICBI) this month. The program supports Indiana Clinical and Translational Sciences Institute’s goal of teaching undergraduate students while giving them hands-on training in translational research and entrepreneurship. Read more…

ICBI company, Scioto Biosciences and Abigail Wexner Research Institute at Nationwide Children’s Hospital Receive a $2.3 Million Dollar Phase II SBIR Grant to Develop Novel Therapy

Friday, August 30, 2019

Scioto Biosciences, a preclinical stage company developing innovative therapies to transform the delivery of microbiome therapeutics, today announced that they are a recipient of a Phase II SBIR grant from the National Institutes of Health (NIH) for $2.3 million. The Phase II award is to continue to support the research with Scioto’s collaborator, the Abigail Wexner Research Institute (AWRI) at Nationwide Children’s Hospital in Columbus, Ohio. The funding will be used to develop Scioto’s proprietary therapeutic SB-121, which is a unique formulation used to deliver healthy, activated probiotic or beneficial bacteria to the gastrointestinal tract. Scioto’s strategy of delivering healthy bacteria to the GI tract can be used to treat a number of different disorders ranging from infectious diseases to disorders effecting the gut-brain axis, such as autism and depression.

Dr. Timothy Hsiao, Program Director at the National Center for Advancing Translational Sciences (NCATS) visited the CTSI incubator, Indiana Center for Biomedical Innovation (ICBI)

Friday, August 30, 2019

The federal government provides various supports for health ventures to strengthen the country’s public health and innovation-driven economy. Dr. H. Timothy Hsiao, the Program Director at the National Center for Advancing Translational Sciences, discussed NIH’s relevant sources of funding and technical assistance, including but not limited to the: Small Business Technology Transfer (R41/R42), Small Business Innovation Research (R43/R44), Research Project Cooperative Agreement (U01). He also, discussed the grant-winning strategies to navigate the NIH funding system to increase the funding success rate.

Q2 Solutions open house ​at the ICBI

Friday, August 30, 2019

Meet the Q2 solutions team at the Indiana Center for Biomedical Innovation (ICBI), Thursday, May 23rdat noon

 Q2 Solutions is a global clinical trial laboratory service organization

Early Hit-to-Lead ADME Screening Services offered by Q2

IU Philanthropic Venture Fund invests in ICBI companies

Friday, August 30, 2019

The Indiana Philanthropic Venture Fund (IU PhV) is on the doorstep of its one-year anniversary and, although not limited to the life sciences, it has funneled $1.6 million into the sector’s early-stage Indiana-based companies. Its visionaries designed the evergreen fund to be a “perpetual resource” and an answer for Indiana University alums who want to support the university and its entrepreneurs.

Launched in March 2018, the $15 million IU PhV has invested in five life sciences startups, two of which were founded by or are led by women. In addition to the $15 million IU committed to the fund, IU PhV aims to raise another $35 million from alumni and supporters of the university. For more information about ICBI companies funded by IU PhV, see link: http:///story/39883779/iu-philanthropic-venture-fund-wraps-first-year-of-perpetual-model

Technology ​Seminar, February 6, 2019

Friday, August 30, 2019

 Meso Scale Discovery

Meso Scale Discovery (MSD) is a global leader in the development, manufacture, and commercialization of innovative assays and instruments for the measurement of molecules in biological samples. MSD provides singleplex and multiplexed assays for neurodegenerative, metabolic inflammation, oncology, toxicology, cell signaling and a broad range of other disease focused biomarkers.


MSD Specialties:

Protein Quantification, Ultrasensitive Immunoassay, Biomarker Testing Service, Assays and Kits, Immunoassay Analyzers Equipment, Assay Development, Immunogenicity Testing, Custom Conjugation Services, Assay Analysis Software

Invention to Startup forum, February 7, 2019

Friday, August 30, 2019

Indiana Center for Biomedical Innovation (ICBI) is hosting an “Invention to Startup forum 

The goal of the Invention to Startup forum is to support advancement of translational research and lab discoveries to enable formation of startup companies.  The forum is designed to provide guidance and mentorship to academic scientists.

Dr. Timothy Corson will talk about the “Novel compounds and targets for blocking neovascularization”.

Dr. Corson is an associate professor in the Department of Ophthalmology, Showalter Scholar and Director of Basic and Translational Research in the Eugene and Marilyn Glick Eye Institute. He is also a member of the IU Melvin and Bren Simon Cancer Center, Stark Neurosciences Research Institute, and Center for Diabetes and Metabolic Diseases

Directions to the Entrepreneur Investor Forum_Oct 16th

Friday, August 30, 2019

Entrepreneur-Investor Forum detailed agenda

Friday, August 30, 2019


Click for more details…….

Friday, August 30, 2019

The First Academic Entrepreneur-Investor Forum

Indiana Center for Biomedical Innovation (ICBI)  is hosting the “Entrepreneur-Investor Forum” on October 16th, 2018. The goal of the event is to bring together the key organizations involved in life sciences entrepreneurial ecosystem in Indianapolis and catalyze collaboration to promote commercialization of life science technologies. The event will be organized in partnership with Indiana-CTSI, Indiana Biosciences Research Institute (IBRI) and Indiana University-Health (IU-Health). Please click here for the detailed agenda for the forum.